In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. As of December 2023, the South East had the highest number of confirmed first episode cases of the virus in the UK with 3,180,101 registered cases, while London had 2,947,727 confirmed first-time cases. Overall, there has been 24,243,393 confirmed cases of COVID-19 in the UK as of January 13, 2023.
COVID deaths in the UK COVID-19 was responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK had the highest death toll from coronavirus in western Europe. The incidence of deaths in the UK was 297.8 per 100,000 population as January 13, 2023.
Current infection rate in Europe The infection rate in the UK was 43.3 cases per 100,000 population in the last seven days as of March 13, 2023. Austria had the highest rate at 224 cases per 100,000 in the last week.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
As of January 12, 2023, COVID-19 has been responsible for 202,157 deaths in the UK overall. The North West of England has been the most affected area in terms of deaths at 28,116, followed by the South East of England with 26,221 coronavirus deaths. Furthermore, there have been 22,264 mortalities in London as a result of COVID-19.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Data for each local authority is listed by:
These reports summarise epidemiological data at lower-tier local authority (LTLA) level for England as at 19 May 2021.
According to a survey conducted in the United Kingdom (UK) as of April 2022, 246 thousand people in the South East of England were estimated to be suffering long COVID symptoms, the highest number across the regions in the UK. In the North West of England a further 218 thousand people were estimated to have long COVID.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Self-reported COVID-19 infections and other respiratory illnesses, including associated symptoms and health outcomes. Joint study with the UK Health Security Agency. These are official statistics in development.
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses in England.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 18 July 2024 to the present.
Please note that after the week 21 report (covering data up to week 20), this surveillance report will move to a condensed summer report and will be released every 2 weeks.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
View the pre-release access list for these reports.
Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.
Between 8 December 2020 and 15 September 2021 5,838,305 1st doses and 5,232,885 2nd doses have been administered to London residents.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Data on activities that respondents have been doing more of since the start of the coronavirus pandemic and will keep doing after the end of the pandemic. Data are based on the COVID-19 module of the OPN, collected between 10 and 14 March 2021.
The coronavirus (COVID-19) pandemic is having a damaging impact on the global hotel industry. Preliminary results for London hotels showed that compared to the same period in 2019, occupancy rates from March 1 to 7, 2020 fell by 21 percent, resulting in a fall in RevPar by 27.7 percent. More recent forecasts in April however showed a much bigger impact on RevPar and occupancy rates,
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.
As of January 29, 2025, the FTSE index stood at 8,557.81 points - well above its average value of around 7,500 points in the past few years.On the 12th of March 2020, amid the escalating crisis surrounding the coronavirus and fears of a global recession, the FTSE 100 suffered the second largest one day crash in its history and the biggest since the 1987 market crash. On the 23rd of March, the FTSE index saw its lowest value this year to date at 4,993.89 but has since began a tentative recovery. With the continuation of the pandemic, the FTSE 100 index was making a tentative recovery between late March 2020 and early June 2020. Since then the FSTE 100 index had plateaued towards the end of July, before starting a tentative upward trend in November. FTSE 100 The Financial Times Stock Exchange 100 Index, otherwise known as the FTSE 100 Index is a share index of the 100 largest companies trading on the London Stock Exchange in terms of market capitalization. At the end of March 2024, the largest company trading on the LSE was Shell. The largest ever initial public offering (IPO) on the LSE was Glencore International plc. European stock exchanges While nearly every country in Europe has a stock exchange, only five are considered major, and have a market capital of over one trillion U.S dollars. European stock exchanges make up two of the top ten major stock markets in the world. Europe’s biggest stock exchange is the Euronext which combines seven markets based in Belgium, France, England, Ireland, the Netherlands, Norway, and Portugal.
Abstract copyright UK Data Service and data collection copyright owner.
The UCL COVID-19 Social Study at University College London (UCL) was launched on 21 March 2020. Led by Dr Daisy Fancourt and Professor Andrew Steptoe from the Department of Behavioural Science and Health, the team designed the study to track in real-time the psychological and social impact of the virus across the UK.
The study quickly became the largest in the country, growing to over 70,000 participants and providing rare and privileged insight into the effects of the pandemic on people’s daily lives. Through our participants’ remarkable two-year commitment to the study, 1.2 million surveys were collected over 105 weeks, and over 100 scientific papers and 44 public reports were published.
During COVID-19, population mental health has been affected both by the intensity of the pandemic (cases and death rates), but also by lockdowns and restrictions themselves. Worsening mental health coincided with higher rates of COVID-19, tighter restrictions, and the weeks leading up to lockdowns. Mental health then generally improved during lockdowns and most people were able to adapt and manage their well-being. However, a significant proportion of the population suffered disproportionately to the rest, and stay-at-home orders harmed those who were already financially, socially, or medically vulnerable. Socioeconomic factors, including low SEP, low income, and low educational attainment, continued to be associated with worse experiences of the pandemic. Outcomes for these groups were worse throughout many measures including mental health and wellbeing; financial struggles;self-harm and suicide risk; risk of contracting COVID-19 and developing long Covid; and vaccine resistance and hesitancy. These inequalities existed before the pandemic and were further exacerbated by COVID-19, and such groups remain particularly vulnerable to the future effects of the pandemic and other national crises.
Further information, including reports and publications, can be found on the UCL COVID-19 Social Study website.
The study asked baseline questions on the following:
It also asked repeated questions at every wave on the following:
Certain waves of the study also included one-off modules on topics including volunteering behaviours, locus of control, frustrations and expectations, coping styles, fear of COVID-19, resilience, arts and creative engagement, life events, weight, gambling behaviours, mental health diagnosis, use of financial support, faith and religion, relationships, neighbourhood satisfaction, healthcare usage, discrimination experiences, life changes, optimism, long COVID and COVID-19 vaccination.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
The main aim of this work is to develop a set of high level macro economic scenarios for the medium-term (to the end of 2022) and for the long-term (to 2030) in order to inform the development of recovery strategies in London, reflecting unprecedented uncertainty on the economic outlook. The primary scenario dimensions include Effectiveness/nature of public health response and Effectiveness/impact of economic support measures. Other scenario dimensions include: Brexit and migration; International economic context; Technology and innovation; Financial climate; Political economy; Economic Geography and GHG emissions. This is an agile project - GLA Economics will continue to track actual data in order to review the assessment of the likelihood of alternative scenario outcomes. Successive updates will be released when they become available for the benefit of external stakeholders in tackling the COVID-19 crisis.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
All data relating to Coronavirus (COVID-19) mortality and long-term outdoor air pollution in London.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
This paper summarises the latest evidence and analysis on the impacts of COVID-19 on London’s economy so far and on the economic outlook so that key actors and stakeholders engaged in responding to the pandemic can have a readily available evidence base to inform policy responses.
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 14 July 2022 to 6 July 2023.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
Russia had over 23 million COVID-19 cases as of October 22, 2023. Over the past week, that figure increased by nearly 20 thousand. Russia had the 10th-highest number of coronavirus (COVID-19) cases worldwide. Debate about COVID-19 deaths in Russia The number of deaths from the disease was lower than in other countries most affected by the pandemic. Several foreign media sources, including New York Times and Financial Times, published articles suggesting that the official statistics on the COVID-19 death toll in Russia could be lowered. A narrow definition of a death from COVID-19 and a general increase in mortality in Moscow were pointed out while suggesting why actual death figures could be higher than reported. Russian explanation of lower COVID-19 deaths Experts and lawmakers from Russia provided several answers to the accusations. Among them were the fact that Russians timely reported symptoms to doctors, a high number of tests conducted, as well as a higher herd immunity of the population compared to other countries. In a letter to the New York Times, Moscow’s health department head argued that even if all the additional death cases in the Russian capital in April 2020 were categorized as caused by the COVID-19, the city’s mortality rate from the disease would still be lower than in cities like New York or London.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Provisional counts of deaths in care homes caused by coronavirus (COVID-19) by local authority. Published by the Office for National Statistics and Care Quality Commission.
There is an urgent need to understand the factors that mediate and mitigate the impact of the Covid-19 pandemic on behaviour and wellbeing. However, the onset of the outbreak was unexpected and the rate of acceleration so rapid as to preclude the planning of studies that can address these critical issues. Coincidentally, in January 2020, just prior to the outbreak in the UK, my team launched a study that collected detailed (~50 minute) cognitive and questionnaire assessments from >200,000 members of the UK public as part of a collaboration with the BBC. This placed us in a unique position to examine how aspects of mental health subsequently changed as the pandemic arrived in the UK. Therefore, we collected data from a further ~120,000 people in May, including additional detailed measures of self-perceived pandemic impact and free text descriptions of the main positives, negatives and pragmatic measures that people found helped them maintain their wellbeing.
In this data archive, we include the survey data from January and May 2020 examining impact of Covid-19 on mood, wellbeing and behaviour in the UK population. This data is reported in a preprint article, where we apply a novel fusion of psychometric, multivariate and machine learning analyses to this unique dataset, in order to address some of the most pressing questions regarding wellbeing during the pandemic in a data-driven manner. The preprint is available on this URL. https://www.medrxiv.org/content/10.1101/2020.06.18.20134635v1
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
Notes:
In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. As of December 2023, the South East had the highest number of confirmed first episode cases of the virus in the UK with 3,180,101 registered cases, while London had 2,947,727 confirmed first-time cases. Overall, there has been 24,243,393 confirmed cases of COVID-19 in the UK as of January 13, 2023.
COVID deaths in the UK COVID-19 was responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK had the highest death toll from coronavirus in western Europe. The incidence of deaths in the UK was 297.8 per 100,000 population as January 13, 2023.
Current infection rate in Europe The infection rate in the UK was 43.3 cases per 100,000 population in the last seven days as of March 13, 2023. Austria had the highest rate at 224 cases per 100,000 in the last week.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.